UK markets open in 4 hours 44 minutes
NIKKEI 225
28,876.72 +4.94 (+0.02%) HANG SENG
20,059.76 +18.90 (+0.09%) CRUDE OIL
88.90 -0.51 (-0.57%) GOLD FUTURES
1,796.50 -1.60 (-0.09%) DOW
33,912.44 +151.39 (+0.45%) BTC-GBP
20,036.49 -544.95 (-2.65%)
QIAGEN N.V. (QIA.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 48.36 |
| Open | 48.60 |
| Bid | 48.62 x 48300 |
| Ask | 48.64 x 51100 |
| Day's range | 48.47 - 48.91 |
| 52-week range | 37.95 - 51.56 |
| Volume | |
| Avg. volume | 506,204 |
| Market cap | 11.038B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 22.54 |
| EPS (TTM) | 2.15 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Jan 2017 |
| 1y target est | 47.90 |
- Business Wire
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
HILDEN, Germany & GERMANTOWN, Md,, August 15, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Viral Vesicular Panel RUO, the first syndromic test to differentiate between monkeypox and five other pathogens which cause similar symptoms.
- Simply Wall St.
Estimating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
How far off is Qiagen N.V. ( NYSE:QGEN ) from its intrinsic value? Using the most recent financial data, we'll take a...
- Zacks
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline
QIAGEN (QGEN) posts better-than-expected results for the second quarter and raises its sales and earnings outlook for 2022 amid the uncertain macroeconomic environment.
© 2022 Yahoo. All rights reserved.
